Overview
- 71 inspections across 61 sites are on record.
- 80 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-16.
At a glance
Inspections
71
Sites
61
Observations
80
Career since
Oct 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lonza Biologics, Inc. | 16 Apr 2026 | Biologics | On file |
| Protein Sciences Corporation | 17 Mar 2026 | Biologics | On file |
| Novartis Pharmaceuticals Corporation | 6 Feb 2026 | Biologics | On file |
| Lonza Houston, Inc | 26 Nov 2025 | Biologics | On file |
| Celgene Corporation | 18 Jul 2025 | Biologics | On file |
Sites inspected
Lonza Biologics, Inc.Portsmouth, United States1 insp.
Protein Sciences CorporationPearl River, United States1 insp.
Novartis Pharmaceuticals CorporationMorris Plains, United States1 insp.
Lonza Houston, IncHouston, United States1 insp.
Celgene CorporationSummit, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Omotunde O Osunsanmi7 shared
Prabhu P Raju4 shared
Paula A Trost4 shared
Cynthia Jim4 shared
Burnell M Henry3 shared
Susan M Jackson3 shared
Jacqueline M Diaz Albert3 shared
Lizaida Perez2 shared
Richard L Bartlett2 shared
Scott T Ballard2 shared
Full investigator report
Get the verbatim findings behind Christian Lynch's 80 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site